Description
INCORPORATE ADDRESS CHANGE FOR NICOTINE CONTRACT
Base award description: 2 LINE ITEMS FOR NICOTINE MINI LOZENGES 36E79721D0038. AWARDED FOR A BASE YEAR AND 4 ONE-YEAR OPTION PERIODS. 7/19/2021 - 7/18/2022 FOR THE BASE YEAR.
Modification chain · 13 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-05-17+$0= $0
- Mod P000012021-12-28+$0= $0
- Mod P000022022-06-16+$0= $0
- Mod P000032022-06-16+$0= $0
- Mod P000042023-05-03+$0= $0
- Mod P000052023-06-21+$0= $0
- Mod P000062023-06-22+$0= $0
- Mod P000072024-02-29+$0= $0
- Mod P000082024-06-25+$0= $0
- Mod P000092024-06-26+$0= $0
- Mod P000102025-06-26+$0= $0
- Mod P000112025-07-21+$0= $0
- Mod P000122026-05-04+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-05-17 | +$0 | $0 | 2 LINE ITEMS FOR NICOTINE MINI LOZENGES 36E79721D0038. AWARDED FOR A BASE YEAR AND 4 ONE-YEAR OPTION PERIODS.… |
| Mod P00001· ADD SUBCONTRACTING PLAN | 2021-12-28 | +$0 | $0 | 2021 SUBCONTRACTING PLAN |
| Mod P00002· ADD SUBCONTRACTING PLAN | 2022-06-16 | +$0 | $0 | INCORPORATE SUBCONTRACTING PLAN FROM 7/1/2022 - 6/30/2023. |
| Mod P00003· EXERCISE AN OPTION | 2022-06-16 | +$0 | $0 | EXERCISING OPTION YEAR 1 FOR NICOTINE MINI LOZENGES WITH NO PRICE CHANGES. PERIOD OF PERFORMANCE FOR THE 1ST O… |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2023-05-03 | +$0 | $0 | ADMINISTRATIVE MODIFICATION TO ADD DRUG SUPPLY CHAIN SECURITY ACT LANGUAGE TO CONTRACT. |
| Mod P00005· EXERCISE AN OPTION | 2023-06-21 | +$0 | $0 | EXERCISE OPTION YEAR 2 FOR NICOTINE MINI LOZENGES WITH THE HARVARD DRUG GROUP, LLC DBA MAJOR PHARMACEUTICALS A… |
| Mod P00006· ADD SUBCONTRACTING PLAN | 2023-06-22 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE APPROVED COMMERCIAL COMPANY WIDE SUBCONTRACTING PLAN INTO THE A… |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-02-29 | +$0 | $0 | CRF AND SALES REPORTING UPDATE |
| Mod P00008· EXERCISE AN OPTION | 2024-06-25 | +$0 | $0 | EXERCISING OPTION YEAR 3. |
| Mod P00009· ADD SUBCONTRACTING PLAN | 2024-06-26 | +$0 | $0 | INCORPORATE HARVARD DRUGS-CARDINAL 24 SUBK PLAN INTO CONTRACT. PLAN IS EFFECTIVE 7-1-2024 UNTIL 6-30-2025. |
| Mod P00010· EXERCISE AN OPTION | 2025-06-26 | +$0 | $0 | EXERCISING OPTION YEAR 4 WITH NO PRICE CHANGES. |
| Mod P00011· ADD SUBCONTRACTING PLAN | 2025-07-21 | +$0 | $0 | INCORPORATE NEW SMALL BUSINESS SUBCONTRACTING PLAN INTO CONTRACT. PLAN IS EFFECTIVE 7-1-2025 UNTIL 6-30-2026. |
| Mod P00012· ENTITY ADDRESS CHANGE | 2026-05-04 | +$0 | $0 | INCORPORATE ADDRESS CHANGE FOR NICOTINE CONTRACT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CBGGKKVNJBK9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79725D0121 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79725D0010 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79725D0001 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79722D0017 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| 36E79721D0048 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
| 36F79719D0033 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2019 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79721D0038_3600 · retrieved 2026-09-26.